TCRα/β+ Depletion Using CliniMacs Prodigy vs CliniMacs Plus Systems: A Head to Head Comparison
Asaf Yanir | BMT, Cell Processing Facillity, Schneider Children's Medical Center of Israel, Petach-Tiqva, Israel
Mesenchymal Stem Cell Coupled with Hematopoietic Stem Cell Transplantation in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
16:45
סגור לתגובות על Mesenchymal Stem Cell Coupled with Hematopoietic Stem Cell Transplantation in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Ronit Elhasid | Pediatric Hematology Oncology, Dana-Dwek Children’s Hospital, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Haploidentical Stem-Cell Transplantation for Children with Acute Leukemia and Non-Malignant Disorders, Using ΑΒ+ T CELL /CD19+ B-cell Depletion, A Single Center Experience
16:37
סגור לתגובות על Haploidentical Stem-Cell Transplantation for Children with Acute Leukemia and Non-Malignant Disorders, Using ΑΒ+ T CELL /CD19+ B-cell Depletion, A Single Center Experience
Amos Toren | Pediatric Hemato-Oncology Division, Sheba Medical Center, Ramat Gan | Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Keynote Lecture | The Future of Pediatric Allogeneic Transplantation in the Context of Cell-and Gene Therapies
16:27
סגור לתגובות על Keynote Lecture | The Future of Pediatric Allogeneic Transplantation in the Context of Cell-and Gene Therapies
Rupert Handgretinger | Dept. of General Pediatrics, Pediatric Hematology Oncology, University Hospital Tuebingen, Germany
Session VI – BMT
16:24
סגור לתגובות על Session VI – BMT
Chairs: Gal Goldstein, Israel Amos Toren, Israe
Hemoglobin S Polymerization and RBC Sickling Evaluation in Sickle Cell
16:22
סגור לתגובות על Hemoglobin S Polymerization and RBC Sickling Evaluation in Sickle Cell
Sari Peretz | Pediatric Hematology Unit and Research Laboratory, Emek Medical Center, Afula | Clinical Laboratory Unit, Emek Medical
Keynote Lecture | New Options in Therapeutics for Sickle Cell Disease
16:17
סגור לתגובות על Keynote Lecture | New Options in Therapeutics for Sickle Cell Disease
Julie Kanter | UAB Adult Sickle Cell Clinic, Division of Hematology Oncology, University of Alabama at Birmingham, USA
Session V – Hematology
14:58
סגור לתגובות על Session V – Hematology
Chairs: Carina Levin, Israel Noa Mandel Shorer, Israel
The Use of Anti GD2 Naxitamab in High Risk Neuroblastoma in Shaare Zedek Medical Center
14:50
סגור לתגובות על The Use of Anti GD2 Naxitamab in High Risk Neuroblastoma in Shaare Zedek Medical Center
Iris Fried | Hematology Oncology, Shaare Zedek Medical Center, Jerusalem, Israel
The Influence of Irinotecan on CD47/PDL-1/GD-2 Expression in Neuroblastoma Cells
14:48
סגור לתגובות על The Influence of Irinotecan on CD47/PDL-1/GD-2 Expression in Neuroblastoma Cells
Tom Lapidus | Goldyne Savad Institute of Gene and Cell Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel
